Anticorps Polyclonal de lapin anti-JMJD3

JMJD3 Polyclonal Antibody for WB, ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain et plus (2)

Applications

WB, ELISA

Conjugaison

Non conjugué

N° de cat : 55354-1-AP

Synonymes

JMJD3, KDM6B, KIAA0346, Lysine-specific demethylase 6B



Applications testées

Résultats positifs en WBcellules A549, cellules HeLa

Dilution recommandée

ApplicationDilution
Western Blot (WB)WB : 1:500-1:2400
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Applications publiées

WBSee 5 publications below

Informations sur le produit

55354-1-AP cible JMJD3 dans les applications de WB, ELISA et montre une réactivité avec des échantillons Humain

Réactivité Humain
Réactivité citéerat, Humain, souris
Hôte / Isotype Lapin / IgG
Clonalité Polyclonal
Type Anticorps
Immunogène Peptide
Nom complet jumonji domain containing 3, histone lysine demethylase
Masse moléculaire calculée 177 kDa
Poids moléculaire observé 177 kDa
Numéro d’acquisition GenBankNM_001080424
Symbole du gène JMJD3
Identification du gène (NCBI) 23135
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par affinité contre l'antigène
Tampon de stockage PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3
Conditions de stockageStocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA.

Informations générales

JMJD3, also known as KDM6B, is a 1643 amino acid protein, which belongs to the UTX family. JMJD3 is a Histone demethylase that specifically demethylates 'Lys-27' of histone H3, thereby playing a central role in histone code (PubMed:17825402, PubMed:17851529, ). JMJD3 demethylates trimethylated and dimethylated H3 'Lys-27', so it Plays a central role in regulation of posterior development, by regulating HOX gene expression (PubMed:17851529). Histone demethylases are epigenetic actors with a crucial role in cancer by acting as suppressors of tumors or as oncogenes. JMJD3 and UTX (ubiquitously transcribed tetratricopeptide repeat, X chromosome) are transcription activators, being specific H3K27me3 demethylases. JMJD3 is involved in many cellular process such as development, differentiation, senescence and aging by p16, p53 and RB pathways and finally inflammation. Depending on cancer type, JMJD3 expression is increased (prostate and breast cancers, melanoma, gliomas, renal cell carcinoma or decreased (lung, liver, pancreatic, colon and colorectal cancers. This role in carcinogenesis has allowed the development of "epidrugs" to modulate JMJD3 expression (PMID: 29805743 ).

Protocole

Product Specific Protocols
WB protocol for JMJD3 antibody 55354-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanWB

Inflammation

Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) Ameliorates the Inflammatory Response in Periodontal Disease.

Authors - Rong Song
mouseWB

Gene

miR-148a-3p regulates adipocyte and osteoblast differentiation by targeting lysine-specific demethylase 6b.

Authors - Lijie Tian
mouseWB

J Physiol

Histone demethylase UTX is a therapeutic target for diabetic kidney disease.

Authors - Hong Chen
ratWB

Stem Cells Dev

Inhibition of Ezh2 In Vitro and the Decline of Ezh2 in Developing Midbrain Promote Dopaminergic Neurons Differentiation Through Modifying H3K27me3.

Authors - Feng Hong
humanWB

Oncol Rep

Targeting P16INK4A in uterine serous carcinoma through inhibition of histone demethylation.

Authors - Zhen Xiao